Kidney function decline is associated with mortality events: over a decade of follow-up from Tehran Lipid and Glucose Study

Background To investigate the association between estimated glomerular filtration rate (eGFR) change and mortality risk in a cohort from the Middle East and North Africa region with increasing chronic kidney disease burden. Methods We included 2210 participants aged ≥ 50 years from the prospective c...

Full description

Saved in:
Bibliographic Details
Published in:Journal of nephrology 2024-01, Vol.37 (1), p.107-118
Main Authors: Masrouri, Soroush, Tamehri Zadeh, Seyed Saeed, Pishgahi, Mehdi, Azizi, Fereidoun, Shapiro, Michael D., Hadaegh, Farzad
Format: Article
Language:English
Subjects:
Cardiovascular Diseases
Creatinine
Follow-Up Studies
Glomerular Filtration Rate
Humans
Iran - epidemiology
Kidney
Lipids
Medicine
Medicine & Public Health
Nephrology
original Article
Prospective Studies
Renal Insufficiency, Chronic - epidemiology
Risk Factors
Urology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background To investigate the association between estimated glomerular filtration rate (eGFR) change and mortality risk in a cohort from the Middle East and North Africa region with increasing chronic kidney disease burden. Methods We included 2210 participants aged ≥ 50 years from the prospective cohort of the Tehran Lipid and Glucose Study. The interval for eGFR measurement was between the examinations in 2002–2005 to 2009–2011, and participants were followed through March 2018. Glomerular filtration rate was estimated from serum creatinine using the CKD-EPI creatinine equation. We assessed the association of rapid kidney function decline, (defined as annual eGFR decline ≥ 3 ml/min/1.73 m 2 per year); ≥ 30% eGFR decline over six years; and certain drop in kidney function (≥ 25% eGFR decline plus drop in eGFR category) with mortality outcomes. Results During a median follow-up of 14.3 years after recruitment, 315 all-cause and 112 cardiovascular disease deaths were recorded. The multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) of all-cause death for rapid kidney function decline, ≥ 30% decline in eGFR over 6 years, and drop in kidney function were 1.68 (1.24–2.27), 2.01 (1.46–2.78), and 1.49 (1.11–1.98), respectively. The HRs of all-cause death and for rapid kidney function decline in those without and with chronic kidney disease were 1.41 (1.03–1.91) and 3.38 (1.69–6.76), respectively. Similar findings were observed regarding cardiovascular disease-related and non-cardiovascular disease-related mortality. Conclusions Estimated GFR decline is associated with an increased mortality risk, indicating its ability to provide additional prognostic information beyond traditional risk predictors in the general population. Graphical abstract
ISSN:1724-6059
1724-6059
DOI:10.1007/s40620-023-01756-z